Ignite Creation Date:
2025-12-24 @ 7:35 PM
Ignite Modification Date:
2025-12-29 @ 5:01 AM
Study NCT ID:
NCT01598103
Status:
TERMINATED
Last Update Posted:
2020-12-19
First Post:
2012-02-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of SAF312 in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord Lesions
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-01
Start Date Type:
None
Primary Completion Date:
2012-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-09
Completion Date Type:
ACTUAL
First Submit Date:
2012-02-17
First Submit QC Date:
None
Study First Post Date:
2012-05-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2020-08-28
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2020-12-11
Last Update Post Date:
2020-12-19
Last Update Post Date Type:
ACTUAL